Lee Jae-Seung, Green Jordan J, Love Kevin T, Sunshine Joel, Langer Robert, Anderson Daniel G
Department of Materials Science and Engineering, Korea University, Seoul, 136-713, Republic of Korea.
Nano Lett. 2009 Jun;9(6):2402-6. doi: 10.1021/nl9009793.
The safe and effective delivery of RNA therapeutics remains the major barrier to their broad clinical application. Here we develop a new nanoparticulate delivery system based on inorganic particles and biodegradable polycations. First, gold nanoparticles were modified with the hydrophilic polymer poly(ethylene glycol) (PEG), and then small interfering RNA (siRNA) was conjugated to the nanoparticles via biodegradable disulfide linkages, with approximately 30 strands of siRNA per nanoparticle. The particles were then coated with a library of end-modified poly(beta-amino ester)s (PBAEs), previously identified as capable of facilitating intracellular DNA delivery. Nanoparticulate formulations developed here facilitate high levels of in vitro siRNA delivery, facilitating delivery as good or better than the commercially available lipid reagent, Lipofectamine 2000.
RNA疗法的安全有效递送仍然是其广泛临床应用的主要障碍。在此,我们开发了一种基于无机颗粒和可生物降解聚阳离子的新型纳米颗粒递送系统。首先,用亲水性聚合物聚乙二醇(PEG)修饰金纳米颗粒,然后通过可生物降解的二硫键将小干扰RNA(siRNA)与纳米颗粒偶联,每个纳米颗粒约有30条siRNA链。然后用一系列末端修饰的聚(β-氨基酯)(PBAE)对颗粒进行包被,PBAE先前已被确定能够促进细胞内DNA递送。此处开发的纳米颗粒制剂有助于高水平的体外siRNA递送,其递送效果与市售脂质试剂Lipofectamine 2000相当或更好。